OCD that hasn't responded to SSRIs or therapy may respond to ketamine.
What OCD is — and why it's hard to treat.
-
OCD affects approximately 2 to 3% of the population — around 1 in 40 adults.
-
40 to 60% of OCD patients do not achieve adequate relief with SSRIs alone.
-
ERP therapy requires significant time, exposure to distress, and patient willingness — not always feasible.
-
Ketamine works on a different neural pathway and can disrupt the OCD cycle where SSRIs cannot.
How ketamine addresses OCD.
Ketamine IV Infusion
- Clinical evidence supports ketamine for treatment-resistant OCD.
- Works by disrupting overactive orbitofrontal-striatal circuits.
- IV delivery allows precise, controlled dosing throughout the infusion.
- Rapid onset — some patients notice relief within 24 to 48 hours of early sessions.
- Paid out of pocket — no insurance approval required.
- Can complement ongoing ERP therapy for enhanced results.
A typical OCD treatment course.
-
Induction phase: 6 infusions over 2 to 3 weeks.
-
Each session runs approximately 1 to 2 hours including monitoring time.
-
You cannot drive home after a session — please arrange a ride.
-
Many OCD patients notice meaningful symptom reduction during the induction phase.
-
Maintenance sessions scheduled based on duration of improvement.
Who is a good candidate for ketamine treatment of OCD.
-
You have been diagnosed with OCD.
-
You have tried one or more SSRIs without sufficient improvement.
-
You have engaged in ERP therapy or been unable to complete it.
-
Your OCD significantly disrupts daily functioning, relationships, or work.
-
You are able to attend a series of infusion sessions and arrange transportation home.
Common questions.
Clinical studies have shown meaningful reductions in OCD symptoms with ketamine IV infusion, including in patients who did not respond to multiple SSRIs. The mechanism is different from standard OCD medications — ketamine targets glutamate pathways rather than serotonin. Results vary by individual, and Dr. Rueda is transparent about realistic expectations during your consultation.
In most cases, yes. Dr. Rueda reviews your full medication list during your evaluation. Continuing ERP therapy alongside ketamine treatment can enhance outcomes. Do not stop any prescribed medication without guidance from your prescribing provider.
Ketamine IV infusion is paid out of pocket for OCD. If your OCD co-occurs with depression, Spravato may be covered by your PPO plan. We verify coverage before your first appointment — call us to discuss your situation.
Some patients notice a reduction in obsessive thoughts or compulsive urges within 24 to 48 hours of early sessions. Others experience more gradual improvement over the induction phase. Individual response varies by severity and treatment history.
